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Diabetes incidence in a high-risk UK population at 7 years: linkage of the 
Prevention of Diabetes and Obesity in South Asians (PODOSA) trial to the 
Scottish Diabetes Register
South Asians are at high risk of type 2 diabetes when living in urbanized environments [1,2]. In 
Europe, South Asians have a prevalence of type 2 diabetes approximately four times greater than 
their white European counterparts, developing the disease and complications, such as 
cardiovascular disease, stroke and kidney disease, earlier [1,3].
Jenum et al. [4] conducted a meta-analysis of six diabetes prevention trials in South Asians with 
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and 20.0% in the control group, the hazard ratio being 0.65 (95% CI 0.51 to 0.81). One  of the 
trials was the Prevention of Diabetes and Obesity in South Asians (PODOSA; trial registration 
number: ISRCTN25729565) study, conducted in Scotland, providing 3-year outcomes. Whether 
interventions in South Asians have benefits beyond the intervention phase is unknown. 
The PODOSA trial started in 2007, with the 3-year outcomes measured in 2012. The original aim 
was to evaluate whether an intervention of 15 dietitian home visits, providing tailored lifestyle 
advice, compared to generic information provided over four visits, would reduce the annual 
incidence of type 2 diabetes in a high-risk South Asian population from an estimated 10% to 5% 
[5]. The trial enrolled 171 people of Indian or Pakistani origin in Edinburgh and Glasgow with 
waist circumference >90 cm (men) and >80 cm (women) and either impaired fasting glucose or 
impaired glucose tolerance. In 2014, the trial reported a 1.6-kg (95% CI –2.83 to 0.44) reduction 
in mean weight in the intervention group compared with the control group and an odds ratio for 
the development of type 2 diabetes of 0.68 (95% CI 0.27 to 1.67) [4,5].
We linked data from the PODOSA trial to the NHS Scottish Care Information (SCI)-Diabetes 
database (hereafter referred to as the 'diabetes register') to obtain 7-year mean follow-up data (Fig. 
1). In 2013, name, sex, address, date of birth and study number (ID) for trial participants were sent 
to the Health Informatics Centre, University of Dundee, to link to the Community Health Index 
(CHI) number, given to users of NHS Scotland. The CHI and ID were sent for linkage to the 
diabetes register, which holds CHI numbers and is considered 99% complete for people with 
diagnosed diabetes in Scotland. The study ID, diabetes type and date of diagnosis were sent to the 
research team between 2014 and 2017, the final linkage being made on 31 October 2017, with 
average 7-year follow-up. For both the 3-year and 7-year outcomes we assumed all incident 
diabetes was type 2 diabetes. Deaths and losses to follow-up during the fieldwork stage of the trial 
were excluded from the analysis. We had no information about deaths that occurred after the 
fieldwork. 
Cox proportional hazards models were adjusted for age, sex, ethnicity (Indian or Pakistani), and 
location (Edinburgh or Glasgow), with intervention as the key exposure. There was no evidence of 
violation of the proportional hazards assumption. Our focus was on adjusted hazard ratios, but for 
comparison with studies using logistic regression (including our own [5]) we calculated odds 
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Participants gave written, informed consent for linkage of their trial data to NHS databases. The 
trial was approved in 2007 by the Scotland A Research Ethics Committee (07-MRE10-2) and this 
linkage by NHS Glasgow and NHS Lothian Caldicott guardians, the London-Fulham Research 
Ethics Committee (17/LO/0826) and NHS Lothian R&D (2017-0134). 
We excluded 7/171 people who had a date of diagnosis of type 2 diabetes in the diabetes register 
before their trial baseline examination date, leaving 164 participants. Of 164 people, 70 (43%) 
developed type 2 diabetes over a mean of 7.0 years of follow-up, 24 with diagnoses via individual 
follow-up between baseline and the end of the trial and 46 by linkage. The incidence of type 2 
diabetes was 6.1% per year; 32/79 people in the intervention group (5.7%/year) and 38/85 people 
in the control group (6.4%/year). 
The hazard ratio for incident type 2 diabetes for the intervention compared to the control group 
was 0.86 (95% CI 0.53–1.38) after adjusting for age, sex, location, ethnicity and baseline BMI 
(Table S1). The corresponding odds ratio was 0.81 (95% CI 0.42–1.56). 
Measuring of trial outcomes through data linkage has been carried previously in Scotland but not 
using the diabetes register [6,7], which allowed us to exclude and add cases. The participants of 
the PODOSA trial had a high incidence of type 2 diabetes, with 6.1% annual progression over 7 
years, similar to the 58.9% progression rate over 10 years in Indians with impaired fasting glucose 
or impaired glucose tolerance in Chennai [8]. Our recruitment criteria, therefore, identified a high-
risk group. The incidence of type 2 diabetes was little different between the intervention  and 
control groups. We found no evidence that benefits of the intervention emerged over time, 
aligning with other trials [9,10]. This study had 83% power to detect a halving of the incidence in 
the intervention group to 22.5% compared with 45% in the control group. Although the study is 
too small to evaluate outcomes, our data will help future meta-analyses, and, in the meantime, 
provide insight into disease progression and the potential of data linkage.
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Supporting information
Additional Supporting Information may be found in the online version of this article: 
Table S1. Hazard ratios and 95% CIs for progression to type 2 diabetes in the intervention vs the 
control group after statistical adjustment for potential confounding factors.
FIGURE 1 Approach to record linkage of Prevention of Diabetes and Obesity in South Asians 
(PODOSA) trial participants to the Scottish Care Information (SCI)-Diabetes database. CHI, 
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